COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03294577
Recruitment Status : Recruiting
First Posted : September 27, 2017
Last Update Posted : May 8, 2020
Information provided by (Responsible Party):
BeyondSpring Pharmaceuticals Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 15, 2020
Estimated Study Completion Date : July 15, 2020